Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Long-term Follow-up of Acute Partial Transverse Myelitis

Long-term Follow-up of Acute Partial Transverse Myelitis ORIGINAL CONTRIBUTION Long-term Follow-up of Acute Partial Transverse Myelitis Bertrand Bourre, MD; He´lène Ze´phir, MD; Jean-Claude Ongagna, CRA; Charlotte Cordonnier, MD, PhD; Nicolas Collongues, MD; Stephanie Debette, MD; Marie-Celine Fleury, MD; Olivier Outteryck, MD; Didier Hannequin, MD, PhD; Patrick Vermersch, MD, PhD; Jerome de Seze, MD, PhD Background: Acute partial transverse myelitis (APTM) (33%), with a mean (SD) age at onset of 36.7 (11.7) years. may be the first clinical symptom of multiple sclerosis At the end of follow-up, 53 patients (62%) were classi- (MS) or may remain a monophasic event. fied as having MS with a mean (SD) Expanded Disabil- ity Status Scale score of 2.6 (1.8), 1 patient (1%) was clas- Objectives: To evaluate the risk of conversion to MS sified as having postinfectious myelitis, 1 (1%) as having and long-term disability, and to determine prognosis fac- neuromyelitis optica, 1 (1%) as having Sjo ¨ gren syn- tors for disability. drome, and 29 (34%) still had APTM of undetermined etiology. Oligoclonal bands in CSF were more frequent Design: We identified patients with no previous his- in patients with MS (92%) than in patients with APTM tory of neurological disease who experienced APTM be- of undetermined etiology (38%). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Loading next page...
 
/lp/american-medical-association/long-term-follow-up-of-acute-partial-transverse-myelitis-Ct3S4tNaCY

References (23)

Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/archneurol.2011.949
pmid
22410443
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL CONTRIBUTION Long-term Follow-up of Acute Partial Transverse Myelitis Bertrand Bourre, MD; He´lène Ze´phir, MD; Jean-Claude Ongagna, CRA; Charlotte Cordonnier, MD, PhD; Nicolas Collongues, MD; Stephanie Debette, MD; Marie-Celine Fleury, MD; Olivier Outteryck, MD; Didier Hannequin, MD, PhD; Patrick Vermersch, MD, PhD; Jerome de Seze, MD, PhD Background: Acute partial transverse myelitis (APTM) (33%), with a mean (SD) age at onset of 36.7 (11.7) years. may be the first clinical symptom of multiple sclerosis At the end of follow-up, 53 patients (62%) were classi- (MS) or may remain a monophasic event. fied as having MS with a mean (SD) Expanded Disabil- ity Status Scale score of 2.6 (1.8), 1 patient (1%) was clas- Objectives: To evaluate the risk of conversion to MS sified as having postinfectious myelitis, 1 (1%) as having and long-term disability, and to determine prognosis fac- neuromyelitis optica, 1 (1%) as having Sjo ¨ gren syn- tors for disability. drome, and 29 (34%) still had APTM of undetermined etiology. Oligoclonal bands in CSF were more frequent Design: We identified patients with no previous his- in patients with MS (92%) than in patients with APTM tory of neurological disease who experienced APTM be- of undetermined etiology (38%).

Journal

JAMA NeurologyAmerican Medical Association

Published: Mar 1, 2012

There are no references for this article.